Healthcare Services

Clinical Biomarkers Market to Reach $59.43B by 2030

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Clinical Biomarkers Market During The Forecast Period?

The clinical biomarkers market has observed substantial expansion in recent years. It is anticipated to expand from $33.75 billion in 2025 to $37.6 billion in 2026, registering a compound annual growth rate (CAGR) of 11.4%. The growth recorded during previous periods is primarily due to an uptick in biomedical research endeavors, a surge in clinical trial volumes, the enhancement of diagnostic testing capabilities, increased uptake of molecular diagnostics, and advancements in analytical technologies.

The clinical biomarkers market is poised for significant expansion in the coming years. Its valuation is expected to reach $59.44 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.1%. This projected growth throughout the forecast period stems from the increasing demand for personalized therapies, rising investments in biomarker-driven drug development, the expansion of translational research programs, the growing utilization of real-world clinical data, and the increasing adoption of advanced sequencing technologies. Key trends anticipated during this period include a greater embrace of precision medicine biomarkers, the rising use of multi-omics biomarker platforms, the growing integration of AI-based biomarker analytics, an expansion in companion diagnostics development, and an enhanced focus on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

What Factors Are Contributing To The Growth Of The Clinical Biomarkers Market?

The increasing aging population is projected to fuel the growth of the clinical biomarker market in the future. An aging population refers to a demographic shift characterized by an increasing proportion of elderly individuals within a society over time. This global aging population is associated with an increased prevalence of age-related diseases, thereby creating a need for biomarkers to improve early diagnosis and disease management. For instance, in February 2025, according to the World Health Organization, a UK-based intergovernmental organization, globally, the population of adults 60 and over is expected to rise from 1.1 billion in 2023 to 1.4 billion by 2030. Therefore, the rising aging population is driving the clinical biomarker market.

How Are Segments Identified Within The Clinical Biomarkers Market Segment Framework?

The clinical biomarkers market covered in this report is segmented –

1) By Offering: Product, Service

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies

3) By Clinical Area: Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Immunological Biomarker, Non-Invasive Prenatal Testing, Other Clinical Areas

4) By Application: Clinical Diagnostic, Translational Research

5) By End User: Contract Research Organizations (CROs), Research And Academic Laboratories, Biopharmaceutical And Biotech Companies, Diagnostic Centers, Other End Users

Subsegments:

1) By Product: Diagnostic Kits, Reagents, Assay Kits, Instruments

2) By Service: Biomarker Discovery Services, Analytical Services, Clinical Trial Services, Data Analysis Services

What Trends Are Shaping The Future Of The Clinical Biomarkers Market?

Major companies operating in the clinical biomarkers market are focusing on developing innovative solutions such as biomarker blood tests. Such a test is a diagnostic method that assesses specific biomolecules present in the blood to provide information about various physiological or pathological conditions in the body. For instance, in July 2023, Quanterix Corporation, a US-based ultra-sensitive digital immunoassay platform developing company, launched ‘LucentAD’. It is a biomarker blood test designed to aid in assessing patients who exhibit cognitive symptoms consistent with the initial indications of Alzheimer’s disease (AD). LucentAD employs the extensively researched Simoa p-Tau 181 assay, which has undergone thorough examination in both large longitudinal and cross-sectional cohorts.

Who Are The Companies Competing Within The Clinical Biomarkers Market?

Major companies operating in the clinical biomarkers market are Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Agilent Technologies Inc., Epigenomics AG, Grifols S.A., Illumina Inc., BioMerieux SA., Charles River Laboratories International Inc., PerkinElmer Inc., Sartorius AG, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Luminex Corporation, Veracyte Inc., Centogene N.V., NanoString Technologies Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Siemens Healthcare Private Limited.

Get The Full Clinical Biomarkers Market Report:

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Which Region Represents The Largest Share Of The Clinical Biomarkers Market?

North America was the largest region in the clinical biomakers market in 2025. The regions covered in the clinical biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Clinical Biomarkers Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Browse Through More Reports Similar to the Global Clinical Biomarkers Market 2026, By The Business Research Company

Oncology Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/oncology-biomarkers-global-market-report

Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Cancer Biomarker Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biomarker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795